Trial intelligence / Profile preview

Exparel vs Bupivacaine for Postoperative Analgesia Following VATS

NCT03859635Phase 3Completed

Sponsor
Indiana University
Start
Feb 2019
Primary completion
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of liposomal bupivacaine in postoperative pain, sponsored by Indiana University. Started Feb 2019; status: completed.

02

Drugs

liposomal bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT03859635.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03859635.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call